You are leaving the BIKTARVY® website.
Leave site Continue Go back Cancel

You are leaving the BIKTARVY® website.

A new window is opening.

Leave site Continue Go back Cancel
You are leaving the BIKTARVY® website.
Leave site Continue Go back Cancel

You are leaving the BIKTARVY® website.

A new window is opening.

Leave site Continue Go back Cancel

Optimizing Treatment

Considerations When Optimizing Regimens

A variety of important factors should be considered in the treatment decision1

Providers may hesitate to change a patient’s regimen, but there may be compelling reasons to do so,
including1:

Reducing pill burden

icon-tolerability

Tolerability and toxicity considerations

Potential drug-drug
interactions

Food requirements

Patient access

Barrier to resistance

How do you approach real-world discussions for switching treatments?

Having conversations around optimizing regimens can help providers and patients who are assessing their options.

Wide Diversity in Clinical Trial Data May Help Inform Treatment Discussions

Increasing the amount of clinical trial data available for specific populations may enhance patient trust2

Increasing diversity and inclusion in clinical trials can provide more generalizable evidence—potentially improving patient trust and advancing health equity. Enhanced patient trust can lead to better retention in care, especially when patients are included as partners.2

While every patient is different, people living with HIV may be inclined towards taking a collaborative approach to shared clinical decision-making.

IN A 2010 STUDY, 7 OUT OF 10

patients preferred to engage in shared decision-making when it came to their HIV treatment (n=434)3

Virologically Suppressed Patients
Resistance Summary

Please see full Prescribing Information for BIKTARVY® and DESCOVY®, including BOXED WARNINGS.

References:

  1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. Updated September 12, 2024. Accessed September 24, 2024. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf
  2. Corneli A, Hanlen-Rosado E, McKenna K, et al. Enhancing diversity and inclusion in clinical trials. Clin Pharmacol Ther. 2023;113(3):489-499.
  3. Kumar R, Korthuis PT, Saha S, et al. Decision-making role preferences among patients with HIV: associations with patient and provider characteristics and communication behaviors. J Gen Intern Med. 2010;25(6):517-523.